ArticleCell reports. Medicine2020

A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury.

Maria Kost-Alimova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.